Examining the efficacy of STD testing public health messages tailored to youth's regulatory focus
Reina Evans-Paulson1, Laura Widman2, Hannah Javidi2
1Innovation Research and Training.
Abstract:
Only 25% of sexually active youth have ever been tested for sexually transmitted diseases (STDs). One potential strategy to increase testing is to target youth with health messages tailored to their regulatory focus. People have a dominant regulatory focus and tend to be either more concerned with the risks of unhealthy choices (prevention-focused) or the benefits of healthy choices (promotion-focused). Theoretically, when someone is targeted with a message that matches their regulatory focus, the message will be more effective. Among 380 sexually active youth, we examined whether matching STD testing messages to youth's regulatory focus strengthens the efficacy of the message for improving STD testing stigma, self-efficacy, and intentions. We evaluated participants' regulatory focus and then assigned them to watch either a prevention-focused or promotion-focused video encouraging STD testing. Among prevention-focused youth, those who watched the prevention-focused video had more stigmatizing attitudes toward STD testing than those who watched the promotion-focused video. Post hoc analyses confirmed the robustness of these findings for our stigma outcome and revealed a similar pattern for self-efficacy: youth who were more prevention-focused and received the prevention-focused video had lower STD testing self-efficacy. Our results for testing intentions were not significant. Interventionists should consider making STD testing messages for youth promotion-focused. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
Related Concept Videos
Drug Regulation
Sexually Transmitted Infections
Drug Control Governance: Regulatory Bodies and Their Impact
Antimicrobial Effectiveness
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...


